COMMUNIQUÉS West-GlobeNewswire

Invivoscribe soumet le test de mutation LeukoStrat CDx FLT3 à la fois aux États-Unis et au Japon pour soutenir la soumission de Daiichi Sankyo pour le quizartinib
28/11/2018
SAN DIEGO, 28 nov. 2018 (GLOBE NEWSWIRE) -- En soutien à un partenariat en cours avec Daiichi Sankyo, Invivoscribe a le plaisir d’annoncer la soumission du test de mutation LeukoStrat ® CDx FLT3 à la fois à la FDA aux [...]
Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction
28/11/2018
TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aquarius Surgical Technologies Inc. (ASTI – CSE) (“the Corporation”) is pleased to announce that Mr. Gordon Willox, has been appointed to the position of President and Chief [...]
Olainfarm invites to Third Quarter 2018 Investor Conference Webinar
28/11/2018
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on December 6, 2018 at 16:00 (EEST). To join the webinar please follow [...]
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
28/11/2018
To Accelerate Precision Medicine Through Globally Proven Experience PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), a [...]
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
28/11/2018
The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world leader in rapid infectious [...]
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018
B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 28, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018
B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 28 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]
ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes
28/11/2018
Geneva, Switzerland and Boston, MA – November 28, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018
B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018
B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 27 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]
Abattis Comments on BCSC Temporary Order
28/11/2018
VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities [...]
Coherus BioSciences Announces New Employment Inducement Grants
28/11/2018
REDWOOD CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective November 14, 2018, the compensation committee of the company’s board of directors granted [...]
Agility Health Announces Director Resignation
27/11/2018
Not for distribution to United States Newswire Services or for dissemination in the United States HAMILTON, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“Agility Health” or, the “Company [...]
MacroGenics Announces Participation in Three Investor Conferences
27/11/2018
ROCKVILLE, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
ContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit
27/11/2018
EDISON, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of liver [...]
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
27/11/2018
Mechelen, Belgium; 27 November 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that the FDA has granted GLPG1972/S201086 Fast Track designation for the treatment of patients with [...]
Acura Pharmaceuticals Announces Third Quarter 2018 Financial Results
27/11/2018
PALATINE, Ill., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine [...]
Catalyst Pharmaceuticals Announces Firdapse® (amifampridine) New Drug Application Continues Under Review
27/11/2018
FDA PDUFA goal date remains tomorrow, November 28, 2018 CORAL GABLES, Fla., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals Inc. (Nasdaq:CPRX) today reports that no decision has yet been received from the [...]
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 30th Annual Healthcare Conference
27/11/2018
TEMPLE CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief [...]

Pages